401 related articles for article (PubMed ID: 25467140)
1. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
2. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
3. Neurological paraneoplastic syndromes in lung cancer patients.
Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
[TBL] [Abstract][Full Text] [Related]
4. Positivity of serum "classical" onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome.
Gromadzka G; Karlińska AG; Łysiak Z; Błażejewska-Hyżorek B; Litwin T; Członkowska A
J Neuroimmunol; 2013 Jun; 259(1-2):75-80. PubMed ID: 23642452
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
[TBL] [Abstract][Full Text] [Related]
6. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
Raspotnig M; Vedeler CA; Storstein A
Acta Neurol Scand Suppl; 2011; (191):83-8. PubMed ID: 21711262
[TBL] [Abstract][Full Text] [Related]
7. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
8. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
10. Onconeural antibodies: improved detection and clinical correlations.
Storstein A; Monstad SE; Haugen M; Mazengia K; Veltman D; Lohndal E; Aarseth J; Vedeler C
J Neuroimmunol; 2011 Mar; 232(1-2):166-70. PubMed ID: 21093932
[TBL] [Abstract][Full Text] [Related]
11. Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
Graus F; Vincent A; Pozo-Rosich P; Sabater L; Saiz A; Lang B; Dalmau J
J Neuroimmunol; 2005 Aug; 165(1-2):166-71. PubMed ID: 15949849
[TBL] [Abstract][Full Text] [Related]
12. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.
Zhang L; Qian W; Chen Q; Yin L; Li B; Wang H
Cell Immunol; 2014 Aug; 290(2):245-50. PubMed ID: 25173445
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers.
Ma J; Wang A; Jiang W; Ma L; Lin Y
Thorac Cancer; 2021 Aug; 12(16):2265-2270. PubMed ID: 34242487
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
16. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
[TBL] [Abstract][Full Text] [Related]
17. Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
Miret M; Horváth-Puhó E; Déruaz-Luyet A; Sørensen HT; Ehrenstein V
PLoS One; 2017; 12(8):e0181564. PubMed ID: 28767671
[TBL] [Abstract][Full Text] [Related]
18. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
Honnorat J
Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of paraneoplastic polyneuropathy in patients with breast cancer and small cell lung cancer].
Koroleva ES; Losenkov IS; Alifirova VM; Ivanova SA; Goldberg VE; Novikova NS
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):93-6. PubMed ID: 24874327
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
